Upgrade to SI Premium - Free Trial

Signal Genetics (SGNL) Enters Agreement with MD Anderson Cancer Center

January 6, 2016 8:31 AM
Signal Genetics, Inc. (NASDAQ: SGNL) announced that the Company has entered into an agreement with the University of Texas MD ...

(Premium-only article. Please sign in or upgrade to SI Premium to view.)

Categories

Corporate News FDA

Next Articles